BMS, Pfizer to present clinical trials data on Eliquis

BMS and Pfizer will present 14 abstracts (oral and poster presentations) at the ESC Congress 2014, organized by the European Society of Cardiology, to be held on August 30 - September 4, 2014 in Barcelona, Spain

ncip

(Photo Courtesy: www.ncip.nci.nih.gov)

The new clinical trial data and New Global Health Economics and Outcomes Research (GHEOR) analyses assessing cost effectiveness and real-world use to reinforce the alliance's commitment to the ongoing analysis of Eliquis in both the nonvalvular atrial fibrillation (NVAF) and venous thromboembolism (VTE).

BMS in a statement also said that 14 abstracts will be presented, including new analysis from the ARISTOTLE, AMPLIFY and AMPLIFY-EXT trials evaluating patients with NVAF and VTE.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X